A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (STELLAR)
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the efficacy and safety of sotatercept treatment
(plus background PAH therapy) versus placebo (plus background PAH therapy) at 24 weeks in
adults with PAH.